Advanced Breast Cancer - OECI
Advanced Breast Cancer - OECI Advanced Breast Cancer - OECI
European School of Oncology Your Education live, free and just a click away! e-ESO sessions weekly e-grandrounds and monthly e-oncoreviews www.e-eso.net Connect every Thursday of each week 1st Tuesday of each month 18:15 CET Learn with our experts and discussants Interact make your questions and receive live answers Access at any time, to any past recorded session (available for 6 months) Get CME and ESMO-MORA credits Play mastermind participant quiz JOIN LIVE AND INTERACT 9:15 SAN FRANCISCO 12:15 BOSTON, NEW YORK 17:15 LONDON, DUBLIN, LISBON 18:15 BRUSSELS, PARIS, MADRID, MILAN, JOHANNESBURG 19:15 ATHENS, TEL AVIV, CAIRO 20:15 MOSCOW 21:45 MUMBAI Your weekly/monthly appointment with education organised without commercial sponsorship by the European School of Oncology in collaboration with
Notes .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. .............................................................................................................................................................................................................................................................. 25
- Page 1 and 2: September-October 2012 Number 50 IT
- Page 3 and 4: Dates and Team By 8 July 2013 Abstr
- Page 5 and 6: General information Venue ABC2 will
- Page 7 and 8: Kimberley L. Blackwell Breast Cance
- Page 9 and 10: Coordinators: Fatima Cardoso Breast
- Page 11 and 12: Preliminary programme outline Wedne
- Page 13 and 14: 10:45 Inoperable locally advanced b
- Page 15 and 16: Abstract submission Deadline for su
- Page 17 and 18: Group registration The online group
- Page 19 and 20: Hotel accommodation Deadline for bo
- Page 21 and 22: Optional tours Viagens Abreu offers
- Page 23: Half day tour to Óbidos and Fátim
- Page 27 and 28: It’s easy to save money on your f
European School of Oncology<br />
Your Education<br />
live, free and just a click<br />
away!<br />
e-ESO sessions<br />
weekly e-grandrounds<br />
and monthly e-oncoreviews<br />
www.e-eso.net<br />
Connect<br />
every Thursday of each week<br />
1st Tuesday of each month<br />
18:15 CET<br />
Learn<br />
with our experts and<br />
discussants<br />
Interact<br />
make your questions and<br />
receive live answers<br />
Access<br />
at any time, to any past<br />
recorded session<br />
(available for 6 months)<br />
Get<br />
CME and ESMO-MORA<br />
credits<br />
Play<br />
mastermind participant<br />
quiz<br />
JOIN LIVE AND INTERACT<br />
9:15 SAN FRANCISCO<br />
12:15 BOSTON, NEW YORK<br />
17:15 LONDON, DUBLIN, LISBON<br />
18:15 BRUSSELS, PARIS, MADRID,<br />
MILAN, JOHANNESBURG<br />
19:15 ATHENS, TEL AVIV, CAIRO<br />
20:15 MOSCOW<br />
21:45 MUMBAI<br />
Your weekly/monthly appointment with education<br />
organised without commercial sponsorship by the<br />
European School of Oncology in collaboration with
Change language